Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Avivagen Inc V.VIV

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Major
Alternate Symbol(s):  CHEXF

Avivagen Inc is a development-stage biotechnology company. The Company develops science-based, natural health products for animals that are proven in clinical trials and offering veterinarians real alternatives to traditional treatments.
Price: $0.05 Volume: 0
Change: $0.00 % Change: 0.00%
Day High/Low: N/A/N/A 52 Week High/Low: 0.11/0.05
Last Traded: October 01, 2015 08:15 Transaction Volume: 11000
Open: Previous Close: 0.05
Bid: 0.05 Ask: 0.055
Bid Size: 417000 Ask Size: 264000
Market Cap: 9.8m Shares Out: 196.7m
PE Ratio: N/A Dividend Yield: N/A

Latest News

2 rail cars leaking crude after oil train derails in northeast Montana

Canadian Press   July 17, 2015
0 stars

North American indices: markets stabilize on conflicting developments

Deals provide optimism, while economic news has sidelined some investors

Colin Cieszynski   November 3, 2009
0 stars

Buffett gets put in Burlington Northern

Oracle of Omaha continues to ride the railroad

Jon Ogg   October 30, 2008
0 stars

Latest Bullboard Posts

  • RE:Wow. Was hoping to drop out at .07

    5 stars

    The good news is no one is selling either. People waiting to see if they will deliver on anticipated contract news. Worth the wait now...

    4.5 stars

  • Wow. Was hoping to drop out at .07

    4 stars

    It appears as even that is slipping out of reach. Keep up the good work Cameron.

    2 stars

  • RE:RE:RE:US news

    5 stars

    Here is what Avivagen is missing:   1) Urgency to buy shares - this is a 2 fold problem, one they are yet to deliver milestones...

    2.5 stars

  • RE:RE:US news

    5 stars

     I am feeling the only way to get traction after seeing year after year a small positive news then one month of nothing is to be...

    2 stars

  • RE:US news

    5 stars

    Just surprising the stock price and volume didnt react more.  The US by far is the largest market so it appears that is where the...

    4.5 stars